| Original language | English |
|---|---|
| Pages (from-to) | S46-S51 |
| Journal | Journal of Clinical Lipidology |
| Volume | 5 |
| Issue number | 3 SUPPL. |
| DOIs | |
| State | Published - Jun 2011 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Future issues, public policy, and public awareness of familial hypercholesterolemias : Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. / Goldberg, Anne C.; Robinson, Jennifer G.; Cromwell, William C.; Ross, Joyce L.; Ziajka, Paul E.
In: Journal of Clinical Lipidology, Vol. 5, No. 3 SUPPL., 06.2011, p. S46-S51.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Future issues, public policy, and public awareness of familial hypercholesterolemias
T2 - Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
AU - Goldberg, Anne C.
AU - Robinson, Jennifer G.
AU - Cromwell, William C.
AU - Ross, Joyce L.
AU - Ziajka, Paul E.
N1 - Funding Information: The January 2011 NLA FH recommendations conference was supported by unrestricted grant funding from the following companies: Abbott Laboratories, Aegerion Pharmaceuticals, Daiichi Sankyo, Genzyme, Kaneka Pharma America LLC, and Merck & Co. The National Lipid Association would like to thank each company for its support of this endeavor. In accordance with the National Lipid Association Code for Interactions with Companies, the NLA maintained full control over the planning, content, quality, scientific integrity, implementation, and evaluation of the recommendations conference and this FH recommendations paper. All related activities are free from commercial influence and bias. Funding Information: Dr. Goldberg has received honoraria related to consulting from Roche/Genentech, ISIS-Genzyme and Merck & Co. Dr. Goldberg has received research grants from Amarin, Abbott Laboratories, GlaxoSmithKline, ISIS-Genzyme Corporation, Merck & Co., Novartis, and Regeneron. Funding Information: Dr. Robinson has received research grants from Abbott Laboratories, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Hoffman LaRoche, Merck & Co., Merck Schering Plough, and Spirocor. Funding Information: Dr. Cromwell has received honoraria related to consulting from Isis Pharmaceuticals, LabCorp, and Health Diagnostics Laboratory. Dr. Cromwell has received research grants from Isis Pharmaceuticals. Dr. Cromwell has received honoraria related to speaking from Abbott Laboratories, LipoScience Inc., Merck & Co., and Merck Schering Plough. Funding Information: Dr. Ziajka has received honoraria related to speaking from Abbott Laboratories, AstraZeneca and Merck & Co. Dr. Ziajka has received research grants from Genzyme Corporation.
PY - 2011/6
Y1 - 2011/6
UR - http://www.scopus.com/inward/record.url?scp=79956265502&partnerID=8YFLogxK
U2 - 10.1016/j.jacl.2011.04.002
DO - 10.1016/j.jacl.2011.04.002
M3 - Article
C2 - 21600529
AN - SCOPUS:79956265502
VL - 5
SP - S46-S51
JO - Journal of Clinical Lipidology
JF - Journal of Clinical Lipidology
SN - 1933-2874
IS - 3 SUPPL.
ER -